ENTITY

IMPACT Therapeutics (IMPACT HK)

31
Analysis
Health Care • Hong Kong

•16 Aug 2026 08:30

APAC Healthcare Weekly (August 16) – Akeso, Fosun Pharma, CSPC Pharma, Daiichi Sankyo, Peptidream

Akeso’s ivonescimab and Daiichi Sankyo’s Enhertu got additional indications approvals in China. CSPC Pharma’s mpox mRNA vaccine candidate got FDA...

Logo
107 Views
Share
•02 Aug 2026 08:30

APAC Healthcare Weekly (August 2) – CSPC, Hengrui, Otsuka, Nippon Shinyaku, PharmaEssnetia, Cipla

Hengrui got NMPA approval for long-acting insulin. FDA approves Otsuka’s new CNS drug. Pharmaessentia announced positive topline result from Phase...

Logo
136 Views
Share
bearish•Cross Asset Strategy
•23 Jan 2023 10:43•Broker

Krungthai XSpring Zoom Eng. January 23, 2023

The SET Index is expected to move sideways, with the support at 1,672/1,660 points and the resistance at 1,690/1,700 points. Tactically, we...

Logo
98 Views
Share
bullish•Cross Asset Strategy
•18 Jan 2023 10:40•Broker

Market Outlook

The SET Index is expected to move sideways, with the support at 1,675/1,670 points and the resistance at 1,690/1,700 points. Technically, the SET...

Logo
96 Views
Share
bullish•Cross Asset Strategy
•11 Jan 2023 10:44•Broker

Market Outlook and Investment Strategy

The SET Index is expected to move sideways, with the resistance at 1,700/1,706 points and the support at 1,685/1,675 points. Tactically, investors...

Logo
99 Views
Share
x